Venus Remedies [VENUSREM] vs Medico Remedies [MEDICO] Detailed Stock Comparison

Venus Remedies Ltd.

NSE
Loading...

Medico Remedies Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Venus Remedies Ltd. wins in 15 metrics, Medico Remedies Ltd. wins in 4 metrics, with 0 ties. Venus Remedies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Venus Remedies Ltd. Medico Remedies Ltd. Better
P/E Ratio (TTM) 16.64 29.19 Venus Remedies Ltd.
Price-to-Book Ratio 2.14 5.06 Venus Remedies Ltd.
Debt-to-Equity Ratio 2.42 18.74 Venus Remedies Ltd.
PEG Ratio 0.54 0.35 Medico Remedies Ltd.
EV/EBITDA 9.49 21.46 Venus Remedies Ltd.
Profit Margin (TTM) 10.85% 6.08% Venus Remedies Ltd.
Operating Margin (TTM) 17.18% 6.03% Venus Remedies Ltd.
EBITDA Margin (TTM) 17.18% 6.03% Venus Remedies Ltd.
Return on Equity 8.08% 16.16% Medico Remedies Ltd.
Return on Assets (TTM) 6.33% 8.43% Medico Remedies Ltd.
Free Cash Flow (TTM) $683.65M $17.05M Venus Remedies Ltd.
1-Year Return 293.07% -11.67% Venus Remedies Ltd.
Price-to-Sales Ratio (TTM) 1.81 1.78 Medico Remedies Ltd.
Enterprise Value $10.48B $3.46B Venus Remedies Ltd.
EV/Revenue Ratio 1.49 1.81 Venus Remedies Ltd.
Gross Profit Margin (TTM) 52.15% 24.84% Venus Remedies Ltd.
Revenue per Share (TTM) $526 $23 Venus Remedies Ltd.
Earnings per Share (Diluted) $57.07 $1.40 Venus Remedies Ltd.
Beta (Stock Volatility) 0.04 0.40 Venus Remedies Ltd.

Venus Remedies Ltd. vs Medico Remedies Ltd. Stock Performance Analysis

Loading Price Chart...

VENUSREM
MEDICO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Venus Remedies Ltd.4.76%11.07%106.51%106.53%140.13%147.60%
Medico Remedies Ltd.-0.70%-2.75%-4.07%7.11%-15.82%-13.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Venus Remedies Ltd.293.07%631.88%1,305.94%1,305.94%354.83%354.89%
Medico Remedies Ltd.-11.67%-51.97%60.67%60.67%60.67%60.67%

Performance & Financial Health Analysis: Venus Remedies Ltd. vs Medico Remedies Ltd.

MetricVENUSREMMEDICO
Market Information
Market Cap i₹12.71B₹3.39B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i65,711213,481
90 Day Avg. Volume i64,772467,545
Last Close₹1,883.00₹42.47
52 Week Range₹416.00 - ₹1,887.30₹30.22 - ₹56.88
% from 52W High-0.23%-25.33%
All-Time High₹1,887.30 (Jun 15, 2026)₹365.05 (Mar 06, 2023)
% from All-Time High-0.23%-88.37%
Growth Metrics
Quarterly Revenue Growth0.02%0.49%
Quarterly Earnings Growth0.31%0.10%
Financial Health
Profit Margin (TTM) i0.11%0.06%
Operating Margin (TTM) i0.17%0.06%
Return on Equity (TTM) i0.08%0.16%
Debt to Equity (MRQ) i2.4218.74
Cash & Liquidity
Book Value per Share (MRQ)₹444.63₹8.07
Cash per Share (MRQ)₹176.40₹0.22
Operating Cash Flow (TTM) i₹883.16M₹-3,720,000
Levered Free Cash Flow (TTM) i₹453.15M₹100.93M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Venus Remedies Ltd. vs Medico Remedies Ltd.

MetricVENUSREM (Apr 26, 2026)MEDICO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i16.6429.19
Forward P/E iN/AN/A
PEG Ratio i0.540.35
Price to Sales (TTM) i1.811.78
Price to Book (MRQ) i2.145.06
Market Capitalization
Market Capitalization i₹12.71B₹3.39B
Enterprise Value i₹10.48B₹3.46B
Enterprise Value Metrics
Enterprise to Revenue i1.491.81
Enterprise to EBITDA i9.4921.46
Risk & Other Metrics
Beta i0.040.40
Book Value per Share (MRQ) i₹444.63₹8.07

Financial Statements Comparison: Venus Remedies Ltd. vs Medico Remedies Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVENUSREM (2025)MEDICO (2025)
Revenue/Sales i6.47B1.49B
Cost of Goods Sold i4.02B1.19B
COGS % of Revenue i62.1%80.1%
Gross Profit i2.45B295.79M
Gross Margin i37.9%19.9%
Research & Development i180.85MN/A
Operating Income (EBIT) i410.23M119.73M
Operating Margin i6.3%8.1%
EBITDA i828.57M173.88M
EBITDA Margin i12.8%11.7%
Pre-Tax Income i718.26M135.04M
Pre-Tax Income % of Revenue i11.1%9.1%
Income Tax i265.12M34.11M
Income Tax % of Revenue i4.1%2.3%
Net Income (Profit) i453.15M100.93M
Profit Margin i7.0%6.8%

Balance Sheet & Liquidity Metrics

MetricVENUSREM (2025)MEDICO (2025)
Cash & Equivalents i575.23M10.95M
Total Current Assets i4.52B966.75M
Total Current Assets % of Revenue i69.8%65.0%
Total Current Liabilities i1.36B569.62M
Total Current Liabilities % of Revenue i21.1%38.3%
Long-Term Debt i03.69M
Long-Term Debt % of Revenue i0.0%0.2%
Total Shareholders Equity i5.61B624.69M
Retained Earnings i2.15B423.00M
Retained Earnings % of Revenue i33.3%28.5%
Property, Plant & Equipment i1.07B5.73M

Cash Flow Statement Comparison

MetricVENUSREM (2025)MEDICO (2025)
Operating Cash Flow i883.16M-3.72M
Operating Cash Flow % of Revenue i13.6%-0.3%
Capital Expenditures i-94.27M-31.83M
Free Cash Flow i683.65M17.05M
FCF Margin i10.6%1.1%
Debt Repayment i-9.54MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVENUSREMMEDICO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i13.37M82.98M
Float Shares i6.37M18.83M
% Held by Insiders i48.62%69.44%
% Held by Institutions i1.15%0.00%
% Held by Public i50.23%30.56%

Dividend Analysis & Yield Comparison: Venus Remedies Ltd. vs Medico Remedies Ltd.

MetricVENUSREMMEDICO
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A